|
Delayed
Nasdaq Stockholm
05:55:32 27/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 1.948 SEK | +0.10% |
|
-5.67% | -1.12% |
| 04:51pm | Irlab Therapeutics Set to Obtain US Patent for Parkinson's Disease Drug Candidate | MT |
| 11:34am | Irlab receives positive patent notice in the US for IRL1117 | FW |
| Market Cap | 29Cr 2.91Cr 2.6Cr 2.4Cr 2.18Cr 4.08Cr 276.57Cr 4.14Cr 11Cr 144.65Cr 11Cr 11Cr 458.01Cr | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 29Cr 2.91Cr 2.6Cr 2.4Cr 2.18Cr 4.08Cr 276.57Cr 4.14Cr 11Cr 144.65Cr 11Cr 11Cr 458.01Cr | EV / Sales 2026 * |
2.86x | EV / Sales 2027 * | 2.02x |
| Free-Float |
83.4% | Yield 2026 * |
-
| Yield 2027 * | - |
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| IRLAB A | Delayed | |
Deutsche Boerse AG
| 6IRA | Delayed | |
|
OTC Markets
| IRLAF | Delayed |
| 1 day | +0.10% | ||
| 1 week | -5.67% | ||
| Current month | +6.68% | ||
| 1 month | +3.29% | ||
| 3 months | +56.34% | ||
| 6 months | +26.66% | ||
| Current year | -1.12% |
| 1 week | 1.86 |  | 2.09 |
| 1 month | 1.7 | | 2.09 |
| Current year | 1.17 | | 2.14 |
| 1 year | 1.17 | | 2.78 |
| 3 years | 1.17 | | 20.2 |
| 5 years | 1.17 | | 51.5 |
| 10 years | 1.17 | | 110 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 01/08/2024 | |
Susanna Waters
PRN | Corporate Officer/Principal | 60 | 01/01/2013 |
Clas Sonesson
CTO | Chief Tech/Sci/R&D Officer | 65 | 01/01/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Rein Piir
BRD | Director/Board Member | 68 | 01/01/2016 |
| Chairman | 73 | 07/05/2020 | |
Veronica Wallin
BRD | Director/Board Member | 40 | 01/01/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/07/26 | Buy | Chairman | 31,000 | 38.8588% | ||
| 01/07/26 | Buy | Chief Technology Officer | 40,16,742 | - | ||
| 01/07/26 | Buy | Chief Executive Officer | 1,83,858 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.10% | -5.67% | -20.16% | -71.77% | 2.91Cr | |
| +0.45% | +3.13% | +54.96% | +125.16% | 1,14000Cr | |
| +0.94% | +4.93% | +39.86% | +78.72% | 64TCr | |
| +0.39% | +1.44% | +25.77% | +97.48% | 51TCr | |
| -0.68% | +1.10% | +47.42% | +65.80% | 38TCr | |
| -3.21% | -2.10% | +60.72% | +33.22% | 35TCr | |
| +0.24% | +1.19% | +24.08% | +52.82% | 29TCr | |
| -0.75% | +1.25% | +1.83% | +26.20% | 27TCr | |
| +1.22% | +4.63% | +52.40% | +64.85% | 24TCr | |
| +1.70% | +3.67% | +31.21% | +102.15% | 20TCr | |
| Average | -0.28% | +2.45% | +31.81% | +57.46% | 40.14TCr | |
| Weighted average by Cap. | -0.54% | +2.98% | +41.55% | +84.06% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10Cr 1.02Cr 90.9L 84.1L 76.14L 1.43Cr 97Cr 1.45Cr 4Cr 51Cr 3.82Cr 3.73Cr 160.17Cr | 14Cr 1.44Cr 1.29Cr 1.19Cr 1.08Cr 2.02Cr 136.85Cr 2.05Cr 5.66Cr 72Cr 5.4Cr 5.28Cr 226.64Cr |
| Net income | -3.61Cr -36.26L -32.43L -30L -27.16L -50.84L -34Cr -51.67L -1.43Cr -18Cr -1.36Cr -1.33Cr -57Cr | 3.46Cr 34.76L 31.08L 28.75L 26.03L 48.72L 33Cr 49.52L 1.37Cr 17Cr 1.3Cr 1.28Cr 55Cr |
| Net Debt | - | - |
Employees
31
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/26/27 | SEK 1.948 | +0.10% | 2,90,341 |
| 26/26/26 | SEK 1.946 | +0.93% | 7,30,010 |
| 23/26/23 | SEK 1.928 | -2.72% | 6,21,231 |
| 22/26/22 | SEK 1.982 | -4.48% | 6,38,431 |
| 21/26/21 | SEK 2.075 | +0.48% | 4,21,941 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IRLAB A Stock
Select your edition
All financial news and data tailored to specific country editions
